{"id":"rv3391a","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a Pierre Fabre Dermo Cosmetique product in phase 3 development, RV3391A is designed for cutaneous application. Without disclosed mechanism details, the compound appears to be investigated for a skin-related indication, potentially involving modulation of inflammatory pathways or keratinocyte function common to dermatological therapeutics.","oneSentence":"RV3391A is a topical agent developed for dermatological use, likely targeting inflammatory or proliferative skin conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:33:06.598Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dermatological indication (specific indication not publicly disclosed)"}]},"trialDetails":[{"nctId":"NCT00709579","phase":"PHASE3","title":"Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids","status":"UNKNOWN","sponsor":"Pierre Fabre Dermo Cosmetique","startDate":"2008-06","conditions":"Cortico Atrophy","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"RV3391A","genericName":"RV3391A","companyName":"Pierre Fabre Dermo Cosmetique","companyId":"pierre-fabre-dermo-cosmetique","modality":"Small molecule","firstApprovalDate":"","aiSummary":"RV3391A is a topical agent developed for dermatological use, likely targeting inflammatory or proliferative skin conditions. Used for Dermatological indication (specific indication not publicly disclosed).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}